# Cirrus Logic, Inc.: financial statements, quarterly

CRUS · Nasdaq · CIK 772406 · [Technology](/sectors/technology.md) · fiscal year ends Mar 27

Pages: [Overview](/companies/crus.md) · [Financials](/companies/crus/financials.md) · [Filings](/companies/crus/filings.md) · [Insiders](/companies/crus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-23) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [481](/filings/0000772406-24-000065.md) | [619](/filings/0000772406-25-000007.md) | [372 d](/filings/0000772406-26-000018.md) | [374](/filings/0000772406-25-000034.md) | [542](/filings/0000772406-25-000041.md) | [556](/filings/0000772406-26-000006.md) | [424 d](/filings/0000772406-26-000018.md) | [407](/filings/0000772406-26-000037.md) | [561](/filings/0000772406-25-000041.md) | [581](/filings/0000772406-26-000006.md) | [449 d](/filings/0000772406-26-000018.md) | [460](/filings/0000772406-26-000037.md) |
| Cost of revenue | $m | [234](/filings/0000772406-24-000065.md) | [302](/filings/0000772406-25-000007.md) | [179 d](/filings/0000772406-26-000018.md) | [185](/filings/0000772406-25-000034.md) | [259](/filings/0000772406-25-000041.md) | [258](/filings/0000772406-26-000006.md) | [198 d](/filings/0000772406-26-000018.md) | [193](/filings/0000772406-26-000037.md) | [267](/filings/0000772406-25-000041.md) | [272](/filings/0000772406-26-000006.md) | [211 d](/filings/0000772406-26-000018.md) | [218](/filings/0000772406-26-000037.md) |
| Gross profit | $m | [247](/filings/0000772406-24-000065.md) | [317](/filings/0000772406-25-000007.md) | [193 d](/filings/0000772406-26-000018.md) | [189](/filings/0000772406-25-000034.md) | [283](/filings/0000772406-25-000041.md) | [298](/filings/0000772406-26-000006.md) | [227 d](/filings/0000772406-26-000018.md) | [214](/filings/0000772406-26-000037.md) | [294](/filings/0000772406-25-000041.md) | [308](/filings/0000772406-26-000006.md) | [238 d](/filings/0000772406-26-000018.md) | [242](/filings/0000772406-26-000037.md) |
| Research and development | $m | [104](/filings/0000772406-24-000065.md) | [113](/filings/0000772406-25-000007.md) | [103 d](/filings/0000772406-26-000018.md) | [105](/filings/0000772406-25-000034.md) | [113](/filings/0000772406-25-000041.md) | [113](/filings/0000772406-26-000006.md) | [103 d](/filings/0000772406-26-000018.md) | [103](/filings/0000772406-26-000037.md) | [110](/filings/0000772406-25-000041.md) | [114](/filings/0000772406-26-000006.md) | [107 d](/filings/0000772406-26-000018.md) | [115](/filings/0000772406-26-000037.md) |
| Selling, general and administrative | $m | [34.3](/filings/0000772406-24-000065.md) | [37.6](/filings/0000772406-25-000007.md) | [36.9 d](/filings/0000772406-26-000018.md) | [36.8](/filings/0000772406-25-000034.md) | [37.8](/filings/0000772406-25-000041.md) | [39.0](/filings/0000772406-26-000006.md) | [37.4 d](/filings/0000772406-26-000018.md) | [38.7](/filings/0000772406-26-000037.md) | [39.6](/filings/0000772406-25-000041.md) | [41.6](/filings/0000772406-26-000006.md) | [39.9 d](/filings/0000772406-26-000018.md) | [42.4](/filings/0000772406-26-000037.md) |
| Operating income | $m | [106](/filings/0000772406-24-000065.md) | [168](/filings/0000772406-25-000007.md) | [52.4 d](/filings/0000772406-26-000018.md) | [46.8](/filings/0000772406-25-000034.md) | [132](/filings/0000772406-25-000041.md) | [146](/filings/0000772406-26-000006.md) | [85.9 d](/filings/0000772406-26-000018.md) | [72.4](/filings/0000772406-26-000037.md) | [145](/filings/0000772406-25-000041.md) | [153](/filings/0000772406-26-000006.md) | [90.3 d](/filings/0000772406-26-000018.md) | [84.4](/filings/0000772406-26-000037.md) |
| Interest expense | $m | [0.2](/filings/0000772406-24-000065.md) | [0.2](/filings/0000772406-25-000007.md) | [0.2 d](/filings/0000772406-26-000018.md) | [0.2](/filings/0000772406-25-000034.md) | [0.2](/filings/0000772406-25-000041.md) | [0.2](/filings/0000772406-26-000006.md) | [0.2 d](/filings/0000772406-26-000018.md) | [0.2](/filings/0000772406-26-000037.md) | [0.2](/filings/0000772406-25-000041.md) | [0.2](/filings/0000772406-26-000006.md) | [0.2 d](/filings/0000772406-26-000018.md) | [0.3](/filings/0000772406-26-000037.md) |
| Income tax | $m | [34.0](/filings/0000772406-24-000065.md) | [33.4](/filings/0000772406-25-000007.md) | [14.8 d](/filings/0000772406-26-000018.md) | [14.5](/filings/0000772406-25-000034.md) | [37.9](/filings/0000772406-25-000041.md) | [37.7](/filings/0000772406-26-000006.md) | [23.3 d](/filings/0000772406-26-000018.md) | [19.9](/filings/0000772406-26-000037.md) | [21.8](/filings/0000772406-25-000041.md) | [22.1](/filings/0000772406-26-000006.md) | [18.5 d](/filings/0000772406-26-000018.md) | [17.3](/filings/0000772406-26-000037.md) |
| Net income | $m | [75.4](/filings/0000772406-24-000065.md) | [139](/filings/0000772406-25-000007.md) | [44.8 d](/filings/0000772406-26-000018.md) | [42.1](/filings/0000772406-25-000034.md) | [102](/filings/0000772406-25-000041.md) | [116](/filings/0000772406-26-000006.md) | [71.3 d](/filings/0000772406-26-000018.md) | [60.7](/filings/0000772406-26-000037.md) | [132](/filings/0000772406-25-000041.md) | [140](/filings/0000772406-26-000006.md) | [81.8 d](/filings/0000772406-26-000018.md) | [76.9](/filings/0000772406-26-000037.md) |
| Diluted EPS | $ per share | [1.34](/filings/0000772406-24-000065.md) | [2.50](/filings/0000772406-25-000007.md) | not reported | [0.76](/filings/0000772406-25-000034.md) | [1.83](/filings/0000772406-25-000041.md) | [2.11](/filings/0000772406-26-000006.md) | not reported | [1.14](/filings/0000772406-26-000037.md) | [2.48](/filings/0000772406-25-000041.md) | [2.66](/filings/0000772406-26-000006.md) | not reported | [1.47](/filings/0000772406-26-000037.md) |
| Basic EPS | $ per share | [1.38](/filings/0000772406-24-000065.md) | [2.57](/filings/0000772406-25-000007.md) | not reported | [0.79](/filings/0000772406-25-000034.md) | [1.92](/filings/0000772406-25-000041.md) | [2.19](/filings/0000772406-26-000006.md) | not reported | [1.17](/filings/0000772406-26-000037.md) | [2.57](/filings/0000772406-25-000041.md) | [2.75](/filings/0000772406-26-000006.md) | not reported | [1.52](/filings/0000772406-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-23) | Q3 FY2024 (2023-12-30) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [278](/filings/0000772406-23-000055.md) | [484](/filings/0000772406-24-000011.md) | [503](/filings/0000772406-25-000014.md) | [491](/filings/0000772406-24-000057.md) | [446](/filings/0000772406-24-000065.md) | [526](/filings/0000772406-25-000007.md) | [540](/filings/0000772406-26-000018.md) | [549](/filings/0000772406-25-000034.md) | [593](/filings/0000772406-25-000041.md) | [778](/filings/0000772406-26-000006.md) | [801](/filings/0000772406-26-000037.md) | [811](/filings/0000772406-26-000037.md) |
| Current assets | $m | [1,097](/filings/0000772406-23-000055.md) | [1,185](/filings/0000772406-24-000011.md) | [1,106](/filings/0000772406-25-000014.md) | [1,102](/filings/0000772406-24-000057.md) | [1,225](/filings/0000772406-24-000065.md) | [1,250](/filings/0000772406-25-000007.md) | [1,240](/filings/0000772406-26-000018.md) | [1,241](/filings/0000772406-25-000034.md) | [1,367](/filings/0000772406-25-000041.md) | [1,409](/filings/0000772406-26-000006.md) | [1,434](/filings/0000772406-26-000037.md) | [1,473](/filings/0000772406-26-000037.md) |
| Total assets | $m | [2,104](/filings/0000772406-23-000055.md) | [2,217](/filings/0000772406-24-000011.md) | [2,232](/filings/0000772406-25-000014.md) | [2,266](/filings/0000772406-24-000057.md) | [2,356](/filings/0000772406-24-000065.md) | [2,363](/filings/0000772406-25-000007.md) | [2,327](/filings/0000772406-26-000018.md) | [2,295](/filings/0000772406-25-000034.md) | [2,430](/filings/0000772406-25-000041.md) | [2,457](/filings/0000772406-26-000006.md) | [2,489](/filings/0000772406-26-000037.md) | [2,560](/filings/0000772406-26-000037.md) |
| Current liabilities | $m | [201](/filings/0000772406-23-000055.md) | [179](/filings/0000772406-24-000011.md) | [186](/filings/0000772406-25-000014.md) | [202](/filings/0000772406-24-000057.md) | [229](/filings/0000772406-24-000065.md) | [211](/filings/0000772406-25-000007.md) | [195](/filings/0000772406-26-000018.md) | [189](/filings/0000772406-25-000034.md) | [210](/filings/0000772406-25-000041.md) | [184](/filings/0000772406-26-000006.md) | [195](/filings/0000772406-26-000037.md) | [194](/filings/0000772406-26-000037.md) |
| Shareholders' equity | $m | [1,708](/filings/0000772406-25-000007.md) | [1,801](/filings/0000772406-25-000007.md) | [1,817](/filings/0000772406-26-000018.md) | [1,848](/filings/0000772406-25-000041.md) | [1,928](/filings/0000772406-26-000006.md) | [1,963](/filings/0000772406-26-000006.md) | [1,949](/filings/0000772406-26-000037.md) | [1,930](/filings/0000772406-26-000037.md) | [2,042](/filings/0000772406-26-000006.md) | [2,103](/filings/0000772406-26-000006.md) | [2,128](/filings/0000772406-26-000037.md) | [2,189](/filings/0000772406-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-23) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(22.7) d](/filings/0000772406-24-000065.md) | [314 d](/filings/0000772406-25-000007.md) | [171 d](/filings/0000772406-26-000018.md) | [87.2](/filings/0000772406-25-000034.md) | [8.2 d](/filings/0000772406-25-000041.md) | [219 d](/filings/0000772406-26-000006.md) | [130 d](/filings/0000772406-26-000018.md) | [116](/filings/0000772406-26-000037.md) | [92.2 d](/filings/0000772406-25-000041.md) | [291 d](/filings/0000772406-26-000006.md) | [151 d](/filings/0000772406-26-000018.md) | [64.1](/filings/0000772406-26-000037.md) |
| Capital expenditure | $m | [8.5 d](/filings/0000772406-24-000065.md) | [9.8 d](/filings/0000772406-25-000007.md) | [7.1 d](/filings/0000772406-26-000018.md) | [10.0](/filings/0000772406-25-000034.md) | [2.7 d](/filings/0000772406-25-000041.md) | [6.7 d](/filings/0000772406-26-000006.md) | [3.4 d](/filings/0000772406-26-000018.md) | [2.6](/filings/0000772406-26-000037.md) | [3.9 d](/filings/0000772406-25-000041.md) | [5.1 d](/filings/0000772406-26-000006.md) | [2.4 d](/filings/0000772406-26-000018.md) | [15.1](/filings/0000772406-26-000037.md) |
| Share repurchases | $m | [40.6 d](/filings/0000772406-24-000065.md) | [56.9 d](/filings/0000772406-25-000007.md) | [50.0 d](/filings/0000772406-26-000018.md) | [41.0](/filings/0000772406-25-000034.md) | [50.0 d](/filings/0000772406-25-000041.md) | [70.0 d](/filings/0000772406-26-000006.md) | [100 d](/filings/0000772406-26-000018.md) | [100.0](/filings/0000772406-26-000037.md) | [40.0 d](/filings/0000772406-25-000041.md) | [70.0 d](/filings/0000772406-26-000006.md) | [70.0 d](/filings/0000772406-26-000018.md) | [31.5](/filings/0000772406-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-24) | Q3 FY2023 (2022-12-24) | Q1 FY2024 (2023-06-24) | Q2 FY2024 (2023-09-23) | Q3 FY2024 (2023-12-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.4](/filings/0000772406-23-000055.md) | [56.6](/filings/0000772406-24-000011.md) | [56.6](/filings/0000772406-24-000057.md) | [56.3](/filings/0000772406-24-000065.md) | [55.6](/filings/0000772406-25-000007.md) | [55.7](/filings/0000772406-25-000034.md) | [55.8](/filings/0000772406-25-000041.md) | [55.1](/filings/0000772406-26-000006.md) | [53.3](/filings/0000772406-26-000037.md) | [53.1](/filings/0000772406-25-000041.md) | [52.7](/filings/0000772406-26-000006.md) | [52.4](/filings/0000772406-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,117,561 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000772406-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.